Challenges in the diagnosis and treatment of pediatric stroke

Lori C Jordan1, Argye E Hillis

  • 1Division of Pediatric Neurology, Department of Neurology, Johns Hopkins University School of Medicine, Suite 2158, 200 North Wolfe Street, Baltimore, MD 21287, USA. ljordan2@jhmi.edu

Insights

Pediatric stroke often results from multiple risk factors, not typical adult ones. Early recognition and specialized research are crucial for effective diagnosis and treatment of childhood stroke.

Area of Science:

  • Pediatric Neurology
  • Neuroscience
  • Vascular Neurology

Background:

  • Childhood stroke differs from adult stroke, rarely linked to hypertension or diabetes.
  • Pediatric stroke often arises from a confluence of multiple risk factors, necessitating comprehensive evaluation.
  • Delayed recognition by caregivers and diagnostic complexities pose significant challenges in pediatric stroke care.

Purpose of the Study:

  • To review recent findings and diagnostic considerations for arterial ischemic stroke and hemorrhagic stroke in children.
  • To highlight the unique challenges in diagnosing and treating pediatric stroke.
  • To emphasize the need for increased awareness and research in pediatric cerebrovascular disorders.

Main Methods:

  • Review of current literature on pediatric stroke.
  • Analysis of diagnostic challenges, including MRI requirements and sedation needs.
  • Examination of treatment research gaps and outcome assessment standardization.

Main Results:

  • Pediatric stroke etiology is multifactorial, distinct from adult risk profiles.
  • Diagnostic accuracy is challenged by overlapping neurological conditions and imaging requirements.
  • Limited clinical research hinders evidence-based treatment strategies for childhood stroke.

Conclusions:

  • Effective management of pediatric stroke requires enhanced caregiver education and awareness.
  • Advancing pediatric stroke care necessitates dedicated clinical research and standardized outcome measures.
  • Addressing the unique diagnostic and therapeutic challenges is paramount for improving outcomes in children with stroke.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...